Cargando…
Regulatory approval for autologous human cells and tissue products in the United States, the European Union, and Japan
Human cells and tissue products belong to a relatively new class of medical products. Therefore, limited information is available on the classification and premarket evaluation of human cells and tissue products in the United States (US), the European Union (EU), and Japan. In this study, the defini...
Autores principales: | Yano, Kazuo, Watanabe, Natsumi, Tsuyuki, Kenichiro, Ikawa, Taisuke, Kasanuki, Hiroshi, Yamato, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581762/ https://www.ncbi.nlm.nih.gov/pubmed/31589662 http://dx.doi.org/10.1016/j.reth.2014.10.001 |
Ejemplares similares
-
Compassionate use of drugs and medical devices in the United States, the European Union and Japan
por: Tsuyuki, Kenichiro, et al.
Publicado: (2016) -
Re-examination of regulatory opinions in Europe: possible contribution for the approval of the first gene therapy product Glybera
por: Watanabe, Natsumi, et al.
Publicado: (2015) -
Non-clinical assessment design of autologous chondrocyte implantation products
por: Ikawa, Taisuke, et al.
Publicado: (2015) -
Bayesian statistics and clinical trial designs for human cells and tissue products for regulatory approval
por: Jokura, Yoji, et al.
Publicado: (2016) -
Comparison of the new Japanese legislation for expedited approval of regenerative medicine products with the existing systems in the USA and European Union
por: Jokura, Yoji, et al.
Publicado: (2017)